A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

NCT00621218 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Rosacea

Interventions

DRUG: tretinoin gel 0.05%
DRUG: vehicle

Sponsor

Coria Laboratories, Ltd.